Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,143.58. The stock has a price-to-earnings ratio of 39.07 and currently yields dividends of 0.58%.
During the trading session on 2026-10-02, Eli Lilly(LLY) shares reached a daily high of $1,164.92 and a low of $1,136.66. At a current price of $1,143.58, the stock is +0.6% higher than the low and still -1.8% under the high.
Trading activity shows a volume of 2.04M, compared to an average daily volume of 2.52M.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
The stock's 52-week range extends from a low of $783.85 to a high of $1,292.65.
LLY News
...
Eli Lilly (LLY) and Company announced that the U.S. Food and Drug Administration FDA has approved an additional indication for Jaypirca, a non-covalent Bruton t...
Investing Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker Eli Lilly just posted a 47.7% revenue surge while rivals like Novo Nordisk are watching...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly and Company (LLY Quick QuoteLLY - Free Report) presented new efficacy data from studies of its marketed and investigational metabolic medicines...
Wedbush downgraded Foghorn Therapeutics (FHTX) to Neutral from Outperform with a price target of $2, down from $10, after the company and Eli Lilly (LLY) electe...
Choosing between the diversified stability of Johnson & Johnson (JNJ -2.30%) and the rapid growth trajectory of Eli Lilly & Co (LLY -0.63%) is a primary conside...
Eli Lilly (NYSE: LLY) reported new Phase 2b and Phase 3 data for EloraTZP and retatrutide in obesity and type 2 diabetes. EloraTZP, which combines eloralintide...
Eli Lilly (LLY -0.61%) has emerged as the leader in the weight-loss market and is posting excellent financial results, partly thanks to its position in this are...
Eli Lilly and Co. (NYSE:LLY) on Thursday announced post-hoc analyses from its ATTAIN-1 study alongside detailed Phase 3 ACHIEVE-4 trial results. The findings d...
Foghorn Therapeutics Inc. (NASDAQ:FHTX) stock is trading lower on Thursday with a session volume of 9.158 million, compared to the average volume of 377.206 tho...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.